Aniruddha Choudhury - Concepedia

Author

Aniruddha Choudhury

Also Known As

A Choudhury, A Raja Choudhury, A. Raja Choudhury, Abhinandan Choudhury, Aniruddha Choudhury, Aniruddha Raja Choudhury, Anita Choudhury

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Sophiahemmet Hospital University of Yamanashi Uppsala University Hospital

About

Aniruddha Choudhury is an author at Karolinska Institutet specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	563
2	Cell Biology	11	11	410
3	Health Sciences	1	1	15
4	Allergy	1	1	23
5	Biostatistics	1	1	15

Aniruddha Choudhury

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Use of Leukemic Dendritic Cells for the Generation of Antileukemic Cellular Cytotoxicity Against Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Aniruddha Choudhury, James Gajewski, Jan C. Liang, Blood	1997	297
Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines Aniruddha Choudhury, Jehad Charo, Sunil K. Parapuram, International Journal of Cancer	2003	141
Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer. Koji Kono, Akihiro Takahashi, Hidemitsu Sugai, PubMed	2002	137
Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor Gustav Ullenhag, Jan‐Erik Frödin, Mahmood Jeddi‐Tehrani, Clinical Cancer Research	2004	90
Expression of MHC Class I on breast cancer cells correlates inversely with HER2 expression Masayuki Inoue, Kousaku Mimura, Shinichiro Izawa, OncoImmunology ImmunogeneticsBreast OncologyHer2 ExpressionCancer ImmunosurveillanceMhc Class	2012	79
Silencing of <i>ROR1</i> and <i>FMOD</i> with siRNA results in apoptosis of CLL cells Aniruddha Choudhury, Katja Derkow, Amir Hossein Daneshmanesh, British Journal of Haematology	2010	71
Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody‐dependent cellular cytotoxicity of EGFR‐ and HER2‐overexpressing esophageal cancer cell lines Kousaku Mimura, Koji Kono, Takanori Maruyama, International Journal of Cancer Esophageal CancerCell DeathPathologyCell GrowthCancer Biology	2011	69
Long-term Idiotype Vaccination Combined with Interleukin-12 (IL-12), or IL-12 and Granulocyte Macrophage Colony-Stimulating Factor, in Early-Stage Multiple Myeloma Patients Lotta Hansson, Amir Osman Abdalla, Ali Moshfegh, Clinical Cancer Research	2007	69
Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria Marzia Palma, Lotta Hansson, Aniruddha Choudhury, Cancer Immunology Immunotherapy VaccinationCancer ImmunosurveillanceImmune Response CriteriaImmunologyTumor Immunity	2011	65
Telomerase (hTERT 611–626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells Parviz Kokhaei, Marzia Palma, Lotta Hansson, Experimental Hematology Hematological MalignancyTumor BiologyLymphoid NeoplasiaCancer ImmunosurveillanceCytotoxic T Cells	2007	61

Page 1